The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA

BACKGROUND: Lisdexamfetamine dimesylate (LDX) demonstrated efficacy in terms of reduced binge eating days per week in adults with binge eating disorder (BED) in two randomized clinical trials (RCTs). OBJECTIVE: The objective of this study was to evaluate the cost effectiveness of LDX versus no pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ágh, Tamás, Pawaskar, Manjiri, Nagy, Balázs, Lachaine, Jean, Vokó, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801997/
https://www.ncbi.nlm.nih.gov/pubmed/26914658
http://dx.doi.org/10.1007/s40261-016-0381-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801997/
https://www.ncbi.nlm.nih.gov/pubmed/26914658
http://dx.doi.org/10.1007/s40261-016-0381-3

Ejemplares similares